- Home
- HBIO vs PMN Comparison
HBIO vs PMN Comparison
Compare HBIO & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- PMN
- Stock Information
- Founded
- HBIO 1901
- PMN 2004
- Country
- HBIO United States
- PMN Canada
- Employees
- HBIO N/A
- PMN N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- PMN Pharmaceuticals and Biotechnology
- Sector
- HBIO Industrials
- PMN Health Care
- Exchange
- HBIO Nasdaq
- PMN Nasdaq
- Market Cap
- HBIO 19.6M
- PMN 16.0M
- IPO Year
- HBIO 2000
- PMN N/A
- Fundamental
- Price
- HBIO $0.45
- PMN $0.45
- Analyst Decision
- HBIO Buy
- PMN Strong Buy
- Analyst Count
- HBIO 2
- PMN 3
- Target Price
- HBIO $3.00
- PMN $4.33
- AVG Volume (30 Days)
- HBIO 1.2M
- PMN 5.2M
- Earning Date
- HBIO 08-11-2025
- PMN 08-07-2025
- Dividend Yield
- HBIO N/A
- PMN N/A
- EPS Growth
- HBIO N/A
- PMN N/A
- EPS
- HBIO N/A
- PMN N/A
- Revenue
- HBIO $91,397,000.00
- PMN N/A
- Revenue This Year
- HBIO N/A
- PMN N/A
- Revenue Next Year
- HBIO $9.75
- PMN N/A
- P/E Ratio
- HBIO N/A
- PMN N/A
- Revenue Growth
- HBIO N/A
- PMN N/A
- 52 Week Low
- HBIO $0.28
- PMN $0.38
- 52 Week High
- HBIO $3.48
- PMN $2.22
- Technical
- Relative Strength Index (RSI)
- HBIO 49.68
- PMN 49.13
- Support Level
- HBIO $0.39
- PMN $0.48
- Resistance Level
- HBIO $0.48
- PMN $1.25
- Average True Range (ATR)
- HBIO 0.03
- PMN 0.10
- MACD
- HBIO -0.00
- PMN 0.01
- Stochastic Oscillator
- HBIO 67.67
- PMN 9.20
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.